eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Abbott Healthcare Products Limited

Solvay Healthcare, Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information e-mail: medinfo.shl@abbott.com
Customer Care direct line: +44 (0)1753 650 099
Medical Information Fax: +44 (0)2380 465 350

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 23/04/2012
PIL Tarka 180mg/2 mg modified-release Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 14/12/2010 and displayed until 23/04/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 18/05/2009 and displayed until 14/12/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change due to harmonisation of PIL.
  • Change of trade or generic name
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change due to user-testing of patient information
Updated on 07/11/2006 and displayed until 18/05/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 08/05/2006 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
Updated on 17/06/2003 and displayed until 08/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 21/08/2000 and displayed until 17/06/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   trandolapril
   verapamil hydrochloride